Global Endocrine Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Endocrine Testing market size was valued at USD 7886.3 million in 2023 and is forecast to a readjusted size of USD 12030 million by 2030 with a CAGR of 6.2% during review period.
The endocrine system is an integrated network that consists of various glands located throughout the body.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.
The Global Info Research report includes an overview of the development of the Endocrine Testing industry chain, the market status of Hospitals (Tandem Mass Spectrometry, Immunoassay), Commercial Laboratories (Tandem Mass Spectrometry, Immunoassay), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endocrine Testing.
Regionally, the report analyzes the Endocrine Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Endocrine Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Endocrine Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Endocrine Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tandem Mass Spectrometry, Immunoassay).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Endocrine Testing market.
Regional Analysis: The report involves examining the Endocrine Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Endocrine Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Endocrine Testing:
Company Analysis: Report covers individual Endocrine Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Endocrine Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Commercial Laboratories).
Technology Analysis: Report covers specific technologies relevant to Endocrine Testing. It assesses the current state, advancements, and potential future developments in Endocrine Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Endocrine Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Endocrine Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Endocrine Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Endocrine Testing, with revenue, gross margin and global market share of Endocrine Testing from 2019 to 2024.
Chapter 3, the Endocrine Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Endocrine Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Endocrine Testing.
Chapter 13, to describe Endocrine Testing research findings and conclusion.
The endocrine system is an integrated network that consists of various glands located throughout the body.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.
The Global Info Research report includes an overview of the development of the Endocrine Testing industry chain, the market status of Hospitals (Tandem Mass Spectrometry, Immunoassay), Commercial Laboratories (Tandem Mass Spectrometry, Immunoassay), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endocrine Testing.
Regionally, the report analyzes the Endocrine Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Endocrine Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Endocrine Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Endocrine Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tandem Mass Spectrometry, Immunoassay).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Endocrine Testing market.
Regional Analysis: The report involves examining the Endocrine Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Endocrine Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Endocrine Testing:
Company Analysis: Report covers individual Endocrine Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Endocrine Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Commercial Laboratories).
Technology Analysis: Report covers specific technologies relevant to Endocrine Testing. It assesses the current state, advancements, and potential future developments in Endocrine Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Endocrine Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Endocrine Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Tandem Mass Spectrometry
- Immunoassay
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centres
- Other Setting
- Abbott Laboratories
- AdnaGen
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- Dako
- DiaSorin
- Eiken
- Fujirebio
- Instrumentation Laboratory
- Kyowa Medex
- Matritech
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Endocrine Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Endocrine Testing, with revenue, gross margin and global market share of Endocrine Testing from 2019 to 2024.
Chapter 3, the Endocrine Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Endocrine Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Endocrine Testing.
Chapter 13, to describe Endocrine Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Endocrine Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Endocrine Testing by Type
1.3.1 Overview: Global Endocrine Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Endocrine Testing Consumption Value Market Share by Type in 2023
1.3.3 Tandem Mass Spectrometry
1.3.4 Immunoassay
1.4 Global Endocrine Testing Market by Application
1.4.1 Overview: Global Endocrine Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Commercial Laboratories
1.4.4 Ambulatory Care Centres
1.4.5 Other Setting
1.5 Global Endocrine Testing Market Size & Forecast
1.6 Global Endocrine Testing Market Size and Forecast by Region
1.6.1 Global Endocrine Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Endocrine Testing Market Size by Region, (2019-2030)
1.6.3 North America Endocrine Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Endocrine Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Endocrine Testing Market Size and Prospect (2019-2030)
1.6.6 South America Endocrine Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Endocrine Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Endocrine Testing Product and Solutions
2.1.4 Abbott Laboratories Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AdnaGen
2.2.1 AdnaGen Details
2.2.2 AdnaGen Major Business
2.2.3 AdnaGen Endocrine Testing Product and Solutions
2.2.4 AdnaGen Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AdnaGen Recent Developments and Future Plans
2.3 Beckman Coulter/Danaher
2.3.1 Beckman Coulter/Danaher Details
2.3.2 Beckman Coulter/Danaher Major Business
2.3.3 Beckman Coulter/Danaher Endocrine Testing Product and Solutions
2.3.4 Beckman Coulter/Danaher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Beckman Coulter/Danaher Recent Developments and Future Plans
2.4 Biomedical Diagnostics
2.4.1 Biomedical Diagnostics Details
2.4.2 Biomedical Diagnostics Major Business
2.4.3 Biomedical Diagnostics Endocrine Testing Product and Solutions
2.4.4 Biomedical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biomedical Diagnostics Recent Developments and Future Plans
2.5 BioMerieux
2.5.1 BioMerieux Details
2.5.2 BioMerieux Major Business
2.5.3 BioMerieux Endocrine Testing Product and Solutions
2.5.4 BioMerieux Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BioMerieux Recent Developments and Future Plans
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business
2.6.3 Bio-Rad Endocrine Testing Product and Solutions
2.6.4 Bio-Rad Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Recent Developments and Future Plans
2.7 Dako
2.7.1 Dako Details
2.7.2 Dako Major Business
2.7.3 Dako Endocrine Testing Product and Solutions
2.7.4 Dako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Dako Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Endocrine Testing Product and Solutions
2.8.4 DiaSorin Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 Eiken
2.9.1 Eiken Details
2.9.2 Eiken Major Business
2.9.3 Eiken Endocrine Testing Product and Solutions
2.9.4 Eiken Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eiken Recent Developments and Future Plans
2.10 Fujirebio
2.10.1 Fujirebio Details
2.10.2 Fujirebio Major Business
2.10.3 Fujirebio Endocrine Testing Product and Solutions
2.10.4 Fujirebio Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fujirebio Recent Developments and Future Plans
2.11 Instrumentation Laboratory
2.11.1 Instrumentation Laboratory Details
2.11.2 Instrumentation Laboratory Major Business
2.11.3 Instrumentation Laboratory Endocrine Testing Product and Solutions
2.11.4 Instrumentation Laboratory Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Instrumentation Laboratory Recent Developments and Future Plans
2.12 Kyowa Medex
2.12.1 Kyowa Medex Details
2.12.2 Kyowa Medex Major Business
2.12.3 Kyowa Medex Endocrine Testing Product and Solutions
2.12.4 Kyowa Medex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Kyowa Medex Recent Developments and Future Plans
2.13 Matritech
2.13.1 Matritech Details
2.13.2 Matritech Major Business
2.13.3 Matritech Endocrine Testing Product and Solutions
2.13.4 Matritech Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Matritech Recent Developments and Future Plans
2.14 Ortho-Clinical Diagnostics
2.14.1 Ortho-Clinical Diagnostics Details
2.14.2 Ortho-Clinical Diagnostics Major Business
2.14.3 Ortho-Clinical Diagnostics Endocrine Testing Product and Solutions
2.14.4 Ortho-Clinical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Endocrine Testing Product and Solutions
2.15.4 Roche Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Roche Recent Developments and Future Plans
2.16 Siemens
2.16.1 Siemens Details
2.16.2 Siemens Major Business
2.16.3 Siemens Endocrine Testing Product and Solutions
2.16.4 Siemens Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Siemens Recent Developments and Future Plans
2.17 Sysmex
2.17.1 Sysmex Details
2.17.2 Sysmex Major Business
2.17.3 Sysmex Endocrine Testing Product and Solutions
2.17.4 Sysmex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sysmex Recent Developments and Future Plans
2.18 Thermo Fisher
2.18.1 Thermo Fisher Details
2.18.2 Thermo Fisher Major Business
2.18.3 Thermo Fisher Endocrine Testing Product and Solutions
2.18.4 Thermo Fisher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Thermo Fisher Recent Developments and Future Plans
2.19 Tosoh
2.19.1 Tosoh Details
2.19.2 Tosoh Major Business
2.19.3 Tosoh Endocrine Testing Product and Solutions
2.19.4 Tosoh Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Tosoh Recent Developments and Future Plans
2.20 Wako
2.20.1 Wako Details
2.20.2 Wako Major Business
2.20.3 Wako Endocrine Testing Product and Solutions
2.20.4 Wako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Wako Recent Developments and Future Plans
2.21 Wallac/PE
2.21.1 Wallac/PE Details
2.21.2 Wallac/PE Major Business
2.21.3 Wallac/PE Endocrine Testing Product and Solutions
2.21.4 Wallac/PE Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Wallac/PE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Endocrine Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Endocrine Testing by Company Revenue
3.2.2 Top 3 Endocrine Testing Players Market Share in 2023
3.2.3 Top 6 Endocrine Testing Players Market Share in 2023
3.3 Endocrine Testing Market: Overall Company Footprint Analysis
3.3.1 Endocrine Testing Market: Region Footprint
3.3.2 Endocrine Testing Market: Company Product Type Footprint
3.3.3 Endocrine Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Endocrine Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Endocrine Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Endocrine Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Endocrine Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Endocrine Testing Consumption Value by Type (2019-2030)
6.2 North America Endocrine Testing Consumption Value by Application (2019-2030)
6.3 North America Endocrine Testing Market Size by Country
6.3.1 North America Endocrine Testing Consumption Value by Country (2019-2030)
6.3.2 United States Endocrine Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Endocrine Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Endocrine Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Endocrine Testing Consumption Value by Type (2019-2030)
7.2 Europe Endocrine Testing Consumption Value by Application (2019-2030)
7.3 Europe Endocrine Testing Market Size by Country
7.3.1 Europe Endocrine Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Endocrine Testing Market Size and Forecast (2019-2030)
7.3.3 France Endocrine Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Endocrine Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Endocrine Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Endocrine Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Endocrine Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Endocrine Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Endocrine Testing Market Size by Region
8.3.1 Asia-Pacific Endocrine Testing Consumption Value by Region (2019-2030)
8.3.2 China Endocrine Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Endocrine Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Endocrine Testing Market Size and Forecast (2019-2030)
8.3.5 India Endocrine Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Endocrine Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Endocrine Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Endocrine Testing Consumption Value by Type (2019-2030)
9.2 South America Endocrine Testing Consumption Value by Application (2019-2030)
9.3 South America Endocrine Testing Market Size by Country
9.3.1 South America Endocrine Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Endocrine Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Endocrine Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Endocrine Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Endocrine Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Endocrine Testing Market Size by Country
10.3.1 Middle East & Africa Endocrine Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Endocrine Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Endocrine Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Endocrine Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Endocrine Testing Market Drivers
11.2 Endocrine Testing Market Restraints
11.3 Endocrine Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Endocrine Testing Industry Chain
12.2 Endocrine Testing Upstream Analysis
12.3 Endocrine Testing Midstream Analysis
12.4 Endocrine Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Endocrine Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Endocrine Testing by Type
1.3.1 Overview: Global Endocrine Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Endocrine Testing Consumption Value Market Share by Type in 2023
1.3.3 Tandem Mass Spectrometry
1.3.4 Immunoassay
1.4 Global Endocrine Testing Market by Application
1.4.1 Overview: Global Endocrine Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Commercial Laboratories
1.4.4 Ambulatory Care Centres
1.4.5 Other Setting
1.5 Global Endocrine Testing Market Size & Forecast
1.6 Global Endocrine Testing Market Size and Forecast by Region
1.6.1 Global Endocrine Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Endocrine Testing Market Size by Region, (2019-2030)
1.6.3 North America Endocrine Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Endocrine Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Endocrine Testing Market Size and Prospect (2019-2030)
1.6.6 South America Endocrine Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Endocrine Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Endocrine Testing Product and Solutions
2.1.4 Abbott Laboratories Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AdnaGen
2.2.1 AdnaGen Details
2.2.2 AdnaGen Major Business
2.2.3 AdnaGen Endocrine Testing Product and Solutions
2.2.4 AdnaGen Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AdnaGen Recent Developments and Future Plans
2.3 Beckman Coulter/Danaher
2.3.1 Beckman Coulter/Danaher Details
2.3.2 Beckman Coulter/Danaher Major Business
2.3.3 Beckman Coulter/Danaher Endocrine Testing Product and Solutions
2.3.4 Beckman Coulter/Danaher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Beckman Coulter/Danaher Recent Developments and Future Plans
2.4 Biomedical Diagnostics
2.4.1 Biomedical Diagnostics Details
2.4.2 Biomedical Diagnostics Major Business
2.4.3 Biomedical Diagnostics Endocrine Testing Product and Solutions
2.4.4 Biomedical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biomedical Diagnostics Recent Developments and Future Plans
2.5 BioMerieux
2.5.1 BioMerieux Details
2.5.2 BioMerieux Major Business
2.5.3 BioMerieux Endocrine Testing Product and Solutions
2.5.4 BioMerieux Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BioMerieux Recent Developments and Future Plans
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business
2.6.3 Bio-Rad Endocrine Testing Product and Solutions
2.6.4 Bio-Rad Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Recent Developments and Future Plans
2.7 Dako
2.7.1 Dako Details
2.7.2 Dako Major Business
2.7.3 Dako Endocrine Testing Product and Solutions
2.7.4 Dako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Dako Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Endocrine Testing Product and Solutions
2.8.4 DiaSorin Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 Eiken
2.9.1 Eiken Details
2.9.2 Eiken Major Business
2.9.3 Eiken Endocrine Testing Product and Solutions
2.9.4 Eiken Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eiken Recent Developments and Future Plans
2.10 Fujirebio
2.10.1 Fujirebio Details
2.10.2 Fujirebio Major Business
2.10.3 Fujirebio Endocrine Testing Product and Solutions
2.10.4 Fujirebio Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fujirebio Recent Developments and Future Plans
2.11 Instrumentation Laboratory
2.11.1 Instrumentation Laboratory Details
2.11.2 Instrumentation Laboratory Major Business
2.11.3 Instrumentation Laboratory Endocrine Testing Product and Solutions
2.11.4 Instrumentation Laboratory Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Instrumentation Laboratory Recent Developments and Future Plans
2.12 Kyowa Medex
2.12.1 Kyowa Medex Details
2.12.2 Kyowa Medex Major Business
2.12.3 Kyowa Medex Endocrine Testing Product and Solutions
2.12.4 Kyowa Medex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Kyowa Medex Recent Developments and Future Plans
2.13 Matritech
2.13.1 Matritech Details
2.13.2 Matritech Major Business
2.13.3 Matritech Endocrine Testing Product and Solutions
2.13.4 Matritech Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Matritech Recent Developments and Future Plans
2.14 Ortho-Clinical Diagnostics
2.14.1 Ortho-Clinical Diagnostics Details
2.14.2 Ortho-Clinical Diagnostics Major Business
2.14.3 Ortho-Clinical Diagnostics Endocrine Testing Product and Solutions
2.14.4 Ortho-Clinical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Endocrine Testing Product and Solutions
2.15.4 Roche Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Roche Recent Developments and Future Plans
2.16 Siemens
2.16.1 Siemens Details
2.16.2 Siemens Major Business
2.16.3 Siemens Endocrine Testing Product and Solutions
2.16.4 Siemens Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Siemens Recent Developments and Future Plans
2.17 Sysmex
2.17.1 Sysmex Details
2.17.2 Sysmex Major Business
2.17.3 Sysmex Endocrine Testing Product and Solutions
2.17.4 Sysmex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sysmex Recent Developments and Future Plans
2.18 Thermo Fisher
2.18.1 Thermo Fisher Details
2.18.2 Thermo Fisher Major Business
2.18.3 Thermo Fisher Endocrine Testing Product and Solutions
2.18.4 Thermo Fisher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Thermo Fisher Recent Developments and Future Plans
2.19 Tosoh
2.19.1 Tosoh Details
2.19.2 Tosoh Major Business
2.19.3 Tosoh Endocrine Testing Product and Solutions
2.19.4 Tosoh Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Tosoh Recent Developments and Future Plans
2.20 Wako
2.20.1 Wako Details
2.20.2 Wako Major Business
2.20.3 Wako Endocrine Testing Product and Solutions
2.20.4 Wako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Wako Recent Developments and Future Plans
2.21 Wallac/PE
2.21.1 Wallac/PE Details
2.21.2 Wallac/PE Major Business
2.21.3 Wallac/PE Endocrine Testing Product and Solutions
2.21.4 Wallac/PE Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Wallac/PE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Endocrine Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Endocrine Testing by Company Revenue
3.2.2 Top 3 Endocrine Testing Players Market Share in 2023
3.2.3 Top 6 Endocrine Testing Players Market Share in 2023
3.3 Endocrine Testing Market: Overall Company Footprint Analysis
3.3.1 Endocrine Testing Market: Region Footprint
3.3.2 Endocrine Testing Market: Company Product Type Footprint
3.3.3 Endocrine Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Endocrine Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Endocrine Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Endocrine Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Endocrine Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Endocrine Testing Consumption Value by Type (2019-2030)
6.2 North America Endocrine Testing Consumption Value by Application (2019-2030)
6.3 North America Endocrine Testing Market Size by Country
6.3.1 North America Endocrine Testing Consumption Value by Country (2019-2030)
6.3.2 United States Endocrine Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Endocrine Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Endocrine Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Endocrine Testing Consumption Value by Type (2019-2030)
7.2 Europe Endocrine Testing Consumption Value by Application (2019-2030)
7.3 Europe Endocrine Testing Market Size by Country
7.3.1 Europe Endocrine Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Endocrine Testing Market Size and Forecast (2019-2030)
7.3.3 France Endocrine Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Endocrine Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Endocrine Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Endocrine Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Endocrine Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Endocrine Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Endocrine Testing Market Size by Region
8.3.1 Asia-Pacific Endocrine Testing Consumption Value by Region (2019-2030)
8.3.2 China Endocrine Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Endocrine Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Endocrine Testing Market Size and Forecast (2019-2030)
8.3.5 India Endocrine Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Endocrine Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Endocrine Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Endocrine Testing Consumption Value by Type (2019-2030)
9.2 South America Endocrine Testing Consumption Value by Application (2019-2030)
9.3 South America Endocrine Testing Market Size by Country
9.3.1 South America Endocrine Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Endocrine Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Endocrine Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Endocrine Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Endocrine Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Endocrine Testing Market Size by Country
10.3.1 Middle East & Africa Endocrine Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Endocrine Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Endocrine Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Endocrine Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Endocrine Testing Market Drivers
11.2 Endocrine Testing Market Restraints
11.3 Endocrine Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Endocrine Testing Industry Chain
12.2 Endocrine Testing Upstream Analysis
12.3 Endocrine Testing Midstream Analysis
12.4 Endocrine Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
